Registration Date 17 Jul 2022
Revision Date 17 Jul 2022

Future Pharm CBD Liposome Hemplets (30 chewable tablets)


Food Supplements

Dietary Supplement


Manufacturer Asserted



Manufacturer's Description

After extensive and innovative research and a patent pending in 2020, Future Pharm is excited to announce the release of HEMPLETS® Liposome Tablets.

What is HEMPLETS®?
HEMPLETS® is the only liposomal chewable tablet in the world that has a patent pending liposome platform. It is designed to have an average particle distribution of 165 Nano meters, increases oral absorbance and bioavailability. HEMPLETS® is designed to deliver a potent dose of CBD that is THC free in an oral tablet form unlike anything else. HEMPLETS® is a highly advanced technology in a solid convenient chewable dosage form.

Why liposomal delivery in HEMPLETS®?
A liposome is a protective lipid layer that encapsulates CBD molecules by using liposomes as carriers. This led to the development of a completely new range of a CBD product that is patent pending. HEMPLETS® liposomal CBD delivers products in chewable flavors that are unmatched in quality and scientifically proven while providing a fast and effective form of CBD supplementation.

What else makes HEMPLETS® unique?
CBD is supplied in the USA by cGMP, FDA registered manufacturers using CO2 extraction. The solvent is considered a cleaner, purer form of extraction because there is no residue after extraction. HEMPLETS® Liposome Chewable Tablets uses all-natural flavors and ingredients.

30 chewable tablets per container
900mg Nano CBD
With CBD Liposome Delivery